{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:25:00Z","timestamp":1741238700874,"version":"3.38.0"},"reference-count":8,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.nephro.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T04:17:43Z","timestamp":1478319463000},"page":"536-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association de sofosbuvir et daclatasvir chez un patient transplant\u00e9 h\u00e9patique trait\u00e9 par h\u00e9modialyse"],"prefix":"10.1684","volume":"12","author":[{"given":"Mourad","family":"Hachicha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Botta-Fridlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2016.05.010_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis\u00a0C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2016.05.010_bib0050","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1681\/ASN.2006070736","article-title":"Hepatitis\u00a0C virus and death risk in hemodialysis patients","volume":"18","author":"Kalantar-Zadeh","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2016.05.010_bib0055","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis\u00a0C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2016.05.010_bib0060","unstructured":"Solvadi\u00ae. Highlights of prescribing information. www.gilead.com\/\u223c\/media\/Files\/pdfs\/medicines\/liver-disease\/sovaldi\/sovaldi_pi.pdf."},{"key":"10.1016\/j.nephro.2016.05.010_bib0065","series-title":"65th\u00a0Annual Meeting of the American association for the study of liver diseases","article-title":"Safety, anti-viral efficacy and pharmacokinetics of sofosbuvir in patients with severe renal impairment","author":"Gane","year":"2014"},{"key":"10.1016\/j.nephro.2016.05.010_bib0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis\u00a0C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.nephro.2016.05.010_bib0075","unstructured":"Daklinza\u00ae. Highlights of prescribing information. http:\/\/packageinserts.bms.com\/pi\/pi_daklinza.pdf."},{"key":"10.1016\/j.nephro.2016.05.010_bib0040","unstructured":"Soci\u00e9t\u00e9 fran\u00e7aise d\u2019h\u00e9patologie (AFEF). Recommandations AFEF sur la prise en charge des h\u00e9patites virales\u00a0C. F\u00e9vrier 2016. www.afef.asso.fr\/ckfinder\/userfiles\/files\/recommandations-textes-officiels\/Recoavril2016.pdf."}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516304849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725516304849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2016.05.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:36:06Z","timestamp":1741192566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725516304849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1769725516304849"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2016.05.010","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association de sofosbuvir et daclatasvir chez un patient transplant\u00e9 h\u00e9patique trait\u00e9 par h\u00e9modialyse","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}